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Abstract
Background: In order to optimise the cost-effectiveness of active surveillance to substantiate freedom from
disease, a new approach using targeted sampling of farms was developed and applied on the example of
infectious bovine rhinotracheitis (IBR) and enzootic bovine leucosis (EBL) in Switzerland. Relevant risk factors (RF) for
the introduction of IBR and EBL into Swiss cattle farms were identified and their relative risks defined based on
literature review and expert opinions. A quantitative model based on the scenario tree method was subsequently
used to calculate the required sample size of a targeted sampling approach (TS) for a given sensitivity. We
compared the sample size with that of a stratified random sample (sRS) with regard to efficiency.
Results: The required sample sizes to substantiate disease freedom were 1,241 farms for IBR and 1,750 farms for
EBL to detect 0.2% herd prevalence with 99% sensitivity. Using conventional sRS, the required sample sizes were
2,259 farms for IBR and 2,243 for EBL. Considering the additional administrative expenses required for the planning
of TS, the risk-based approach was still more cost-effective than a sRS (40% reduction on the full survey costs for
IBR and 8% for EBL) due to the considerable reduction in sample size.
Conclusions: As the model depends on RF selected through literature review and was parameterised with values
estimated by experts, it is subject to some degree of uncertainty. Nevertheless, this approach provides the
veterinary authorities with a promising tool for future cost-effective sampling designs.
Background
Documented freedom from disease is the basis for inter-
national free trade of animals and animal products. In
Switzerland, annual serological surveys are conducted to
substantiate freedom from infectious bovine rhinotra-
cheitis (IBR), enzootic bovine leucosis (EBL), Brucella
melitensis, Aujeszky’s disease and porcine reproductive
and respiratory syndrome (PRRS). Switzerland is free of
IBR and EBL since 1994. Therefore, a very low preva-
lence is considered for sample size calculation and, in
consequence, a large sample size is required to demon-
strate freedom from disease [1]. Thus, this active sur-
veillance approach is costly and personnel-intensive.
The development of cost-effective tools for animal dis-
ease surveillance is therefore of high interest to scien-
tists and decision-makers in the field of veterinary
public health.
One approach to increase the efficiency of active sur-
veillance is targeting high-risk strata in the animal popu-
lation, termed risk-based surveillance, or in the context
of this manuscript called targeted sampling (TS). It is
based on the identification and utilisation of specific,
scientifically documented quantitative risk factors for
occurrence of the respective diseases [2]. In conven-
tional approaches to document disease freedom, a sam-
ple of farms is selected randomly from a central
database. Randomness is necessary to ensure representa-
tiveness for induction on the population. Random sam-
pling can be done in strata without violating the
assumption of representativeness. However, random
sampling does not take into account uneven distribution
of disease risk. Thus, it is the best choice only in
absence of information on the distribution of disease
risk. When such information is available, this can be
used to formulate risk strata. Consequently, testing
high-risk strata offers a potential of detecting disease* Correspondence: daniela.hadorn@bvet.admin.ch
2Swiss Federal Veterinary Office, Berne, Switzerland
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with a higher probability or a smaller sample size com-
pared to testing non high-risk strata [2].
The aims of our study were to evaluate the perfor-
mance and cost-effectiveness of a TS approach com-
pared with conventional stratified random sampling
(sRS) using stochastic scenario tree modelling [1,3]. Our
study diseases for this task were IBR and EBL in Swiss
cattle, the freedom of which we wanted to demonstrate
at a maximum herd prevalence of 0.2% with an overall
sensitivity of 99% [4]. Within the scope of this paper,
the level of confidence yielded by a surveillance system
is referred to as its sensitivity.
Methods
Evaluation of risk factors for IBR and EBL
The first step of the study consisted in identifying rele-
vant risk factors (RF) for disease occurrence on indivi-
dual cattle farms. A literature review on the
epidemiology of IBR and EBL was conducted with a
focus on specific RF for the diseases and their relevance
for the Swiss cattle population, given that the population
is considered to be free of these diseases. Lists of RF
were generated and discussed with national experts
within the field resulting in a final, strongly condensed
selection of RF for both diseases (Table 1). As all cattle
farms are registered in the animal movement database
(TVD), the chosen RF could be allocated to the affected
farms by means of the TVD and the geographical soft-
ware ArcGis 9, ArcMap Version 9.2 (ESRI Inc.) provid-
ing us with an Excel list (Microsoft Corporation 2007)
of all 52,176 Swiss cattle farms and their corresponding
RF for IBR and EBL for the year 2008.
To allow quantitative comparison of information con-
tent or gain of RFs - either single or combined - these
had to be parameterised. To allocate values to the
selected RF, we chose a modified Delphi approach for
the gathering of expert opinion [5]. An electronic ques-
tionnaire, seeking estimations on the minimum, the
most likely and the maximum values of relative risks
(RR) for the selected RF (i.e. the expert-based change in
disease risk compared to a baseline RF level) was sent to
15 experts in the field of veterinary epidemiology, veter-
inary virology and veterinary public health. We formu-
lated the questions without giving a desired range for
Table 1 Risk factors for the introduction of IBR and EBL into Swiss cattle farms
Risk factor (RF) Farms exposed to RF Definition of the risk involved
IBR
Animal contacts (AC) All farms which send their cattle, or part of it, to summer
pastures (inside the country or across the border) and/or let
their bovines participate in cattle shows
Physical contacts with potentially infected bovines from
other farms
Higher-than-average
animal movements on
farm (AM)
All farms having more cattle entries on farm per year than
the yearly median value for their herd size category
Farms which purchase many bovines from outside have a
higher risk of getting an IBR-positive animal into their herd
than farms which do not purchase any cattle
Farm close to the
border with another
country (FcB)
All cattle farms situated up to 5 km from the Swiss border
and 500 m at most from a larger road (in this zone)
Uncontrolled contacts between potentially infected animals;
airborne transmission of pathogens; veterinarians from
neighbouring countries treating cattle (having contact with
potentially IBR-infected animals); facilitated illegal importation
of bovines
High density of cattle
farms in the vicinity
(hDH)
All farms that have many (in our case >21) neighbouring
farms within a radius of 1 km around their farm
Uncontrolled contacts between animals (over fences), or
between animals and persons (neighbouring families,
visitors...)
Importation of cattle
(IC)
All farms having imported cattle in their herds Even though cattle destined for importation must originate
from IBR-free herds, or, in the case of non-IBR-free countries,
have to be tested for IBR, an introduction of the disease
through cattle importation can never be excluded
EBL
Higher-than-average
animal movements on
farm (AM)
All farms that have more cattle entries on farm per year
than the yearly median value for their herd size category
Farms which purchase many bovines from outside, have a
higher risk of getting an EBL-positive animal in their herd
than farms which do not purchase any cattle
Importation of cattle
(IC)
All farms having imported cattle in their herds Even though cattle destined for importation must originate
from EBL-free herds, or, in the case of non-EBL-free
countries, have to be tested for EBL, an introduction of the
disease through cattle importation can never be excluded
Summer pasture with
animals from other
herds (SP)
All farms which send their cattle, or part of it, on summer
pastures (inside the country or across the border)
This risk factor implicates lengthy physical contacts between
animals from different herds and therefore makes a
transmission of EBL from one bovine to another possible;
cattle are exposed to biting and stinging insects in the
summer season (® transmission of infected lymphocytes)
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the RR values. Thus, the experts were boundless free to
name their estimates. The same questionnaire, supple-
mented with the median values of all RR estimates from
the first round was sent to the experts a second time,
offering them the possibility to either adjust their esti-
mates for the RR or to confirm their previous values.
The final results considered for the parameterisation of
the RF were the median values of all estimates from the
second questioning round.
Adaptation and development of the scenario tree model
A scenario tree models the process of disease detection
through a surveillance system component (SSC), tracing
the probabilities that a single unit (eg. farm) will yield
either a positive or a negative outcome. The tree
includes all factors affecting the probability of infection
or detection of a surveillance unit (Figure 1). Scenario
tree modelling is used to calculate the sensitivity of a
SSC for a given design prevalence and sample size [3].
The scenario tree models described in literature so far
are mostly used to calculate the sensitivity of a SSC for
a given sample size and design prevalence [1,3]. In our
use of the scenario tree method, we also aimed at calcu-
lating a sample size to demonstrate disease freedom for
a given sensitivity and at a given prevalence. Hence, the
SSC evaluated in our study was the annual serological
survey for IBR and EBL. We also wanted to determine
the risk factor combinations (eq. risk strata) that yielded
the highest information gain, so as to choose as many
farms as possible from these high-risk strata and, in
consequence, keep the sample size minimal. We para-
meterised two models (one for IBR, one for EBL) using
the corresponding data for the respective diseases and
modelled two sampling scenarios, one hypothetical and
one practical, for each disease.
Input parameters
In the scenario tree model, we used a design prevalence
at the herd level (P*H) of 0.2% for both IBR and EBL
(Table 2). We defined the proportions (PrRF) of the
selected risk factors for Swiss cattle farms as well as
their RR (RRRF) (Table 2) for the calculation of the
adjusted risks and the effective probabilities of infection
(EPI) for each combination of risk factors and hence,
every single farm [1,3]. The medians of the minimum,
the most likely and the maximum values for the RR
determined through expert opinion were modelled as
pert distributions in @Risk 5.0 (Palisade Corporation)
and run with 1000 iterations. The test sensitivities for
the antibody-ELISAs (CHEKIT® Trachitest Serum,
IDEXX Laboratories and CHEKIT® Leucose Serum,
IDEXX Laboratories) used for the annual serological
surveys in Switzerland were set at 99.3% for IBR and
99.9% for EBL. These values were obtained from the
Swiss reference laboratories for IBR and EBL (Table 2).
All animals per herd are tested and a herd is already
classified positive if only one single sample shows a
positive reaction. Therefore, the values for the herd sen-
sitivities are equal to the values of the diagnostic test (=
single unit) sensitivities. The specificity of both ELISA-
tests was set at 100%, since Switzerland is free of both
diseases and every positive test result would consistently
be retested with additional diagnostic tests until con-
firmed positive or negative. Therefore, the model does
not account for false positive results.
Model Outputs
With the adapted scenario tree model, we were able to
calculate the sensitivity of a certain targeted risk stratum
using the following equation described by Martin et al.
[3]:
CSe = 1− (1− SUSe)n (1)
where CSe (component sensitivity) is the sensitivity of
a certain risk stratum, SUSe (system unit sensitivity) cor-
responds to the average probability that one randomly
selected farm out of a certain risk stratum will yield a
positive outcome, given that the country is infected at
P*H. SUSe is calculated by summing up the limb prob-
abilities for all limbs with positive outcomes in the sce-
nario tree model.
The sample size n for conducting a random sample or
a targeted sample in a certain risk stratum required to
reach a given sensitivity CSe can be calculated by solving
equation (1) for n:
n = log(1−SUSe)(1− CSe) (2)
As we were interested in calculating a sample size
containing farms from different, especially high-risk
strata, we needed to combine the CSe of several targeted
Figure 1 Conceptual schematic of the scenario tree for the
annual serological survey to demonstrate freedom from EBL in
Switzerland. For IBR, the same procedure applies, but with 5
instead of 3 risk factors (RF).
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risk strata to an overall SSe (system sensitivity) for all
selected risk strata. This was done using the following
equation described by Martin et al. [3]:
SSe = 1−
∏j
j=1
(1− CSej) (3)
where J denotes the number of risk strata considered
and CSej corresponds to the sensitivity for the j-th risk
stratum.
(a) Using exclusive targeted sampling For both dis-
eases, a theoretical scenario involving solely TS in the
highest risk stratum was modelled. In this scenario, only
farms possessing all RF for the respective diseases,
meaning that they were classified in the risk stratum
with the greatest information gain, were considered for
sampling. However, this implies that enough farms com-
prising each of the studied RF must exist, which, in rea-
lity was not the case. Exclusive TS in a practical
sampling scenario is also possible. However, this means
that farms from several risk strata would have to be
considered for testing. The reduction in sample size
would then be smaller than in the hypothetical scenario
mentioned above, where only farms from the highest
risk stratum are considered.
(b) Combining targeted and random sampling in one
sampling scheme In order to make use of the informa-
tion gain of TS but without compromising the represen-
tativeness of the survey with a very small targeted
sample size, we combined TS with a baseline stratified
random sample (bsRS). This combined approach
cTS&bsRS is conducted as follows: First, the sensitivity
of a bsRS has to be determined. In our example, we
decided to conduct a bsRS with a sensitivity of 90%. The
sample size for the bsRS was calculated using equation
(2) and instead of targeting a certain risk stratum, we
ran the scenario tree model distributing the PrRF as they
appear in the population, so as to obtain a sample cho-
sen randomly out of all risk strata.
In order to reach the overall sensitivity (OSe) of 99% for
the documentation of freedom from disease, the required
SSe for the TS component can be calculated using the
following formula, modified from Hadorn et al. [6]:
Table 2 Input parameters used in the scenario tree model to substantiate freedom from IBR and EBL in Switzerland
Description of input parameter Value Source
Herd-level design prevalence for disease freedom from IBR and EBL (P*H) 0.002 OIE Animal Health Code 2010
Proportions of risk factors for IBR in the cattle farm population (PrRF)
Proportion of “animal contacts” (PrAC) 0.401 TVD
1
Proportion of “animal movements” (PrAM) 0.286 TVD
1
Proportion of “farm close to border” (PrFcB) 0.100 TVD
1
Proportion of “high density of herds” (PrhDH) 0.123 TVD
1
Proportion of “importation of cattle” (PrIC) 0.002 TVD
1
Proportions of risk factors for EBL in the cattle farm population (PrRF)
Proportion of “animal movements” (PrAM) 0.286 TVD
1
Proportion of “importation of cattle” (PrIC) 0.002 TVD
1
Proportion of “common summer pasture” (PrSP) 0.398 TVD
1
Relative risks (RRRF) of risk factors for IBR
RR of “animal contacts” (RRAC) RiskPert(2; 4; 6) Expert opinion
2
RR of “animal movements” (RRAM) RiskPert(2; 4; 6) Expert opinion
2
RR of “farm close to border” (RRFcB) RiskPert(2; 4; 6) Expert opinion
2
RR of “high density of herds” (RRhDH) RiskPert(1; 2; 3) Expert opinion
2
RR of “importation of cattle” (RRIC) RiskPert(2; 4; 6) Expert opinion
2
Relative risks (RRRF) of risk factors for EBL
RR of “animal movements” (RRAM) RiskPert(1; 2; 3) Expert opinion
2
RR of “importation of cattle” (RRIC) RiskPert(1.5; 4; 5) Expert opinion
2
RR of “common summer pasture” (RRSP) RiskPert(1; 1.5; 3) Expert opinion
2
ELISA test-sensitivities for herd serology (TSensSH)
TSensSH of IBR-Antibody-ELISA (CHEKIT
® Trachitest Serum, IDEXX Laboratories) 0.993 Swiss Reference Laboratory for IBR3
TSensSH of EBL-Antibody-ELISA (CHEKIT
® Leucose Serum, IDEXX Laboratories) 0.999 Swiss Reference Laboratory for EBL4
1Swiss Animal Movement Database (2008)
2Modified Delphi approach
3Institute of Virology, University of Zurich
4Institute of Veterinary Virology, University of Berne
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x =
(OSe− CSebsRS)
(1− CSebsRS) (4)
where x is the required SSe for the TS component,
OSe the required overall sensitivity of cTS&bsRS and
CSebsRS the sensitivity of the baseline random sample
(Figure 2).
Analysis of cost-effectiveness
To compare the cost-effectiveness of the cTS&bsRS
approach with that of sRS, we identified the differences
in each step of the planning and implementation of the
annual serological surveillance programme for the two
methods. We then determined the costs linked to each
step of the programme, based on already available data
from the Swiss Federal Veterinary Office (FVO) (unpub-
lished data: Sonia Menéndez, “Costs of surveillance sys-
tems (2008)”, Monitoring Department, Federal
Veterinary Office) and compared the resulting full sur-
vey costs for both approaches.
In Switzerland, all cattle over two years of age on
selected survey farms are tested for IBR and EBL [7].
In order to get an estimate of cost for budgeting, we
calculated the net costs of the samples (material and
analysis) for the average number of individual animals
to be tested per farm at 20 for randomly selected
farms (which corresponds to the long-time average
[7]), and in targeted selected farms at 30 animals per
farm due to the larger average herd sizes in “risk
farms” (corresponding to an average of 30 animals per
farm, as deduced from our data). The detailed effec-
tive costs have to be calculated at the end of the
survey.
Results
Evaluation of risk factors for IBR and EBL
As a result of the literature review and expert opinion
survey, we identified the five following relevant RF for
the introduction of IBR into Swiss cattle farms together
with the corresponding sets of minimum, most likely
and maximum values for their RR (in brackets): animal
contacts (2/4/6), over-average animal movements (2/4/6),
farm close to the border (2/4/6), importation of cattle (2/
4/6) and high density of herds in the vicinity (1/2/3)
(Table 1) [8-27]. With five RF and two possible out-
comes (yes/no) each, we could generate 32 (= 25) possi-
ble different combinations of RF, meaning that we had
32 risk strata for IBR available in the scenario tree
model. As a result, we could assert that ~ 40% (20,870)
of all cattle farms had no RF for IBR, whereas only one
farm (~ 0.002%) had all five RF for the disease.
For EBL, the following three RF were determined,
together with the corresponding sets of minimum,
most likely and maximum values for their RR (in
brackets): importation of cattle (1.5/4/5), over- average
animal movements (1/2/3), and summer pasture with
other herds (1/1.5/3) (Table 1) [28-45]. With three risk
factors and two possible outcomes, we could generate
8 (= 23) different risk strata for the EBL model.
~51.5% (26,870) of all cattle farms had no RF for EBL,
while ~ 0.07% (40) of the farms had all three RF apply-
ing to them.
Adaptation and development of the scenario tree model
(a) Using exclusive targeted sampling
The theoretical sample sizes of the scenario involving
solely TS in the highest risk stratum ranged from 21 to
58 farms (yielding a 99% sensitivity on the 95%- and
5%-percentile, respectively, on the distribution for CSe)
for IBR and 208 to 486 farms (95%- and 5%-percentile,
respectively) for EBL.
(b) Combining targeted and random sampling in one
sampling scheme
The sample sizes for bsRS resulted in 1,158 and 1,150
farms for IBR and EBL, respectively. The difference of 8
farms between IBR and EBL is explained by the differ-
ence in the test sensitivity for the two diseases (Table
2). The SSe required for the TS component calculated
with equation 4 accounted for 90% in order to reach an
OSe of 99% (Figure 2). The sample sizes for the TS
component selected out of the highest risk strata for the
respective diseases consisted of 83 farms for IBR and
600 farms for EBL in order to yield 90% sensitivity on
the 5%-percentile. We used the results on the 5%-per-
centile as a conservative approach in defining the sam-
ple sizes for the TS component (Figure 3).
Figure 2 Conceptual schematic representing the process of
combining targeted sampling with baseline random sampling
to substantiate freedom from disease. TS is the targeted
sampling component, bsRS denotes the baseline stratified random
sampling component with the sensitivity CSebsRS, cTS&bsRS is the
combination of targeted and random sampling, OSe is the required
overall sensitivity to demonstrate freedom from disease and X
represents the sensitivity of the TS component, the value of which
can be calculated using eq. (4).
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For sampling, the farms, as they actually existed in
reality, were successively selected out of the highest risk
strata until the required SSe was reached. For IBR, this
resulted in: the only farm out of the highest risk stratum
with all RF present; all of the two farms out of the stra-
tum with the RF AC, AM, FcB and IC present and 80
farms out of 125 actually available farms in the stratum
with the RF AC, AM, FcB, and hDH present. For EBL
this resulted in: all of the 40 farms out of the highest
risk stratum with all RF present; all of the 18 farms out
of the risk stratum with RF AM and IC; all of the 8
farms out of the risk stratum with RF SP and IC; all of
the 34 farms out of the risk stratum with the RF IC and
500 farms out of actually 10,439 available farms of the
risk stratum with RF SP and AM present.
Using cTS&bsRS, the total minimal sample sizes
required were therefore 1,241 herds for IBR and 1,750
herds for EBL on the 5%-percentile. In comparison, a
sRS with an overall sensitivity of 99% calculated with the
software Freecalc (Moffsoft™) and using the test sensi-
tivities mentioned in Table 2 consisted of 2,259 farms to
be tested for IBR and 2,243 farms to be tested for EBL.
Analysis of cost-effectiveness
The annual serological survey for IBR and EBL in Swit-
zerland is planned and conducted by the FVO in Berne.
The samples are then collected by official veterinarians
in the Regional Veterinary Offices (RVO, cantons) and
sent to different diagnostic laboratories approved by the
FVO for analysis. In case positive results are detected,
samples are sent to the reference laboratories for IBR or
EBL for confirmatory analysis. The evaluation and
reporting of the results of the survey is again carried out
by the FVO. The process of planning and implementa-
tion of the survey is basically identical for both
cTS&bsRS and sRS. However, cTS&bsRS requires addi-
tional administrative effort and expenses for the annual
updating of the RF per farm.
Using the values for the number of blood samples to
be collected mentioned in the methods section, 25,650
individual blood samples were needed to substantiate
freedom from IBR and 41,160 samples to demonstrate
freedom from EBL using cTS&bsRS. Conventional sRS
would require 45,180 individual blood samples to be
tested for IBR and 44,860 samples for EBL.
The total costs for an IBR survey using cTS&bsRS
amounted to 580,600 € (exchange ratio CHF/€ = 1.5),
while a sRS cost 964,800 €. The total expenses for an
EBL survey using cTS&bsRS added up to 880,100 €,
while a sRS cost 955,900 € (Table 3).
Discussion
With the approach described in this paper, we devel-
oped a user-friendly instrument for the design of risk-
based sampling programmes, providing veterinary
authorities with a promising tool for future, cost-effec-
tive sampling strategies. Taking the gain in information
of testing high-risk strata into account, we are able to
considerably reduce the sample size. Especially for IBR,
a reduction by almost half of the samples was achieved.
We explain this fact by the larger number of relevant
RF identified and the higher values for their respective
RR compared to EBL. Another influential factor in this
context is the larger number of farms available in the
highest risk strata for IBR compared to EBL. The analy-
sis of cost-effectiveness clearly revealed a financial bene-
fit of cTS&bsRS, when compared to exclusive sRS for
both IBR and EBL.
In the case of the theoretical scenario involving solely
TS in the highest risk stratum, the reduction in sample
size compared to sRS would be major. However, this
scenario is hypothetical and based on the assumption
that we have a large number of farms available in the
Figure 3 Distribution of the system sensitivity (SSe) of the
targeted sampling component (TS) for IBR (n = 83 farms) and
EBL (n = 600 farms).
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highest risk stratum, which in reality is not the case.
Nevertheless, it would be possible to conduct solely TS
by considering all available farms in the different risk
strata with the highest information gain and conse-
quently to further decrease the necessary sample size.
But the eventual geographical clustering of an entirely
targeted sample due to uneven spread of risk would be
a disadvantage in terms of representativeness and cover-
age of a survey in many regions or countries. The pro-
posed approach of cTS&bsRS assures the
representativeness of the survey, while at the same time
taking into account the advantages of TS.
The stochastic scenario tree model to calculate CSe or
n of the TS component depends on RF selected through
literature review, parameterised with estimates based on
expert opinion and is therefore subject to some degree
of uncertainty. However, the distributions used for the
RR and in consequence, consideration of conservative
results on the 5%-percentile of the distribution for the
CSe of TS provides a certain counterbalance for this
issue. A survey based on cTS&bsRS guarantees an OSe
of at least over CSebsRS in case the estimations for the
RF and RR should have been completely inadequate.
Furthermore, the percentage of CSebsRS on the OSe and
therefore the degree of uncertainty can be varied and
defined according to requirements. It has to be noted
that correlation or dependence between RF was not
considered in this study. The participants of the expert
opinion survey were left free to assign any value to the
RR of the evaluated RF. Although it is possible that
experts intuitively considered some degree of correlation
or dependence between RF, this issue was not addressed
in the survey design.
Because a classical validation of a model with reliable
field data is nearly impossible for rare diseases, we
chose to verify the accuracy of our RF for IBR with
past, well documented cases of the disease [46,47]. All
of the three Swiss IBR outbreak farms from the canton
of Jura in 2009 had at least one RF applying to them.
One farm even had four RF. Consequently, those farms
would have a high probability of being selected for a
survey based on cTS&bsRS. For EBL however, even
this attempt of validation was difficult to achieve, as
only very few, poorly documented cases of leucosis
actually occurred in Switzerland since the eradication
of the disease.
Further surveillance components for IBR and EBL in
Switzerland, such as passive clinical surveillance, slaugh-
terhouse inspection and abortion examination, were not
taken into account in this project as we aimed at analys-
ing the legally prescribed annual serological survey only.
Additionally, we simulated and analysed the effect of
varying input parameters on the SSC and directly
explored the effects of several exchangeable parameters
on the OSe. We did this using different values for PrRF
and RRRF and checking if the scenario tree model pro-
duced logical results.
The problem of testing the same farms year by year
can be reduced by a yearly updating of the risk factors
per farm. This is a recommended procedure anyway, as
RF for the cattle farms can change over time. More
importantly, the bsRS has a certain compensational
function also in this respect. Furthermore, if a large
number of farms are available in a selected high risk
stratum, the farms can be selected randomly within this
risk stratum, and not all farms of a certain risk stratum
would have to be tested. A verification of the accuracy
of and, in consequence, updating of the RF and the RR
in regular time intervals (i.e. every 5 years) is also a
strategy to consider.
Table 3 Comparison of costs for the annual serological survey to substantiate freedom from IBR and EBL using
conventional stratified random sampling (sRS) and combined targeted and baseline stratified random sampling
(cTS&bsRS) (figures based on data by S. Menéndez, Swiss Federal Veterinary Office (2008), exchange ratio CHF/€ = 1.5)
Number of
herds
to be tested
Number of
individual
blood samples
Costs for the planning of the
survey
Costs for sampling
and
laboratory analysis
Total costs for the full
survey5
IBR
sRS 2,259 45,1801 8,700 € 912,000 € 964,800 €
cTS&bsRS 1,241 25,6502 11,800 €3 524,500 € 580,600 €
EBL
sRS 2,243 44,8601 8,700 € 903,100 € 955,900 €
cTS&bsRS 1,750 41,1602 11,800 €3 824,000 € 880,100 €
1 The average number of animals to be tested (eq. individual samples) per farm was set at 20 for randomly selected farms.
2 The average number of animals to be tested (eq. individual samples) per farm was set at 30 for farms selected targeted and at 20 for farms selected randomly
(baseline sample).
3Additional administrative expenses for updating of “risk farms”.
4 The costs include farm visits, sampling labour and material, shipment/postage expenses and laboratory costs.
5 The costs for the evaluation and reporting of the survey results do not differ between the two methods and are therefore not mentioned separately in the
table, but are included in the total costs of the survey.
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The different approaches described in this paper are
all based on whole herd testing which corresponds to
the sampling framework of IBR and EBL in Switzerland
to demonstrate absence of disease on the farm level.
However, the model described in this paper can also be
modified for diseases with increased within-herd preva-
lence. For such diseases, the within-herd prevalence has
to be included as an additional infection node in the
scenario tree model.
Conclusions
Combined targeted and baseline stratified random sam-
pling is a cost-effective approach for the substantiation
of disease freedom and therefore has a potential to be
implemented in the annual serological surveys for IBR
and EBL in Switzerland. The scenario tree model
described in this study can be modified, extended and
further developed in order to fit other diseases and
objectives for targeted surveillance in Switzerland and
other countries.
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